Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coral snake venom toxin proteins are a diverse mixture of biologically active proteins and peptides found in the venom of coral snakes (especially of the genus Micrurus). The major protein groups include three-finger toxins (3FTx), phospholipases A2 (PLA2s), Kunitz-type serine protease inhibitors, WAPrin-type inhibitors, C-type lectin-like proteins, and occasional metalloproteinases[1][2][4]. These toxins act through multiple mechanisms—including blocking or disrupting neuromuscular signaling (neurotoxicity), lysing muscle cells (myotoxicity), degrading extracellular matrix and vasculature (hemotoxicity), and inhibiting serine proteases—ultimately leading to paralysis, respiratory failure, and tissue injury in envenomated victims[2][3]. Unlike a singular molecular target (such as a receptor or enzyme), "coral snake venom toxin proteins" collectively refer to a complex set of toxic targets rather than a discrete molecular entity. This complexity enables the venom to affect multiple physiological pathways simultaneously, complicating both clinical management and research targeting these components for novel drug leads[4]. Note: - This entry is considered incorrect as a "single target" because coral snake venom is a complex mixture containing numerous protein families, each with its own structure, function, and pharmacology, not a single molecular entity[2][4]. The answer would need to focus on a specific toxin (e.g., "Three-finger toxin from Micrurus species") for structured, target-level details.
Antivenom: Binds to and neutralizes toxic proteins; Inhibitory antibodies (experimental): Targeting specific toxin families (e.g., 3FTx, PLA2)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coral snake venom toxin protein.